| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 152, Issue 8 4149-4156, Copyright © 1994 by American Association of Immunologists
ARTICLES |
AE Koch, LA Harlow, GK Haines, EP Amento, EN Unemori, WL Wong, RM Pope and N Ferrara
Department of Medicine, Northwestern University Medical School, Chicago, IL 60611.
Angiogenesis is important in the proliferation of inflammatory synovial tissue. Vascular endothelial growth factor (VEGF) is an endothelial cell mitogen that is also angiogenic in vivo. We examined the potential role of VEGF in mediating chemotaxis and proliferation of endothelial cells in rheumatoid arthritis (RA) using samples of synovial tissue and synovial fluid from 55 arthritic patients. Synovial fluid VEGF by ELISA was higher in RA synovial fluids (386 +/- 122 ng/ml) (SE) compared with osteoarthritis (OA) synovial fluids (< 0.8 ng/ml) (p < 0.05) or synovial fluids from patients with other arthritides (6.6 +/- 2 ng/ml). In addition to its known mitogenic properties, we found that human rVEGF was chemotactic for HUVECs at concentrations above 0.02 nM. Incubation of RA synovial fluids with neutralizing anti-VEGF resulted in 23 to 66% (mean 53 +/- 4%) inhibition of HUVEC chemotaxis. Conditioned medium from four of five RA synovial tissue explants was mitogenic for bovine adrenal capillary endothelial cells. Anti-VEGF neutralized from 19 to 42% (mean 28 +/- 4%) of this mitogenic activity. To determine the cellular source of VEGF in synovial tissue, we employed immunohistochemistry. VEGF+ cells were rarely (< 1%+) found in normal synovial tissues. In contrast, RA and OA synovial tissues exhibited VEGF+ lining cells (8% and 13%, respectively). A few synovial tissue macrophages were VEGF+ in both RA and OA (5% and 2%, respectively). These results elucidate a newly described function for VEGF as a potent chemotaxin for endothelial cells as well as a role for VEGF in RA-associated endothelial migration and proliferation.
This article has been cited by other articles:
|
|
 |
|
  Y. C. Yung, J. Chae, M. J. Buehler, C. P. Hunter, and D. J. Mooney Cyclic tensile strain triggers a sequence of autocrine and paracrine signaling to regulate angiogenic sprouting in human vascular cells PNAS, September 8, 2009; 106(36): 15279 - 15284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. SIEMANN, C. M. NORRIS, A. RYAN, and W. SHI Impact of Tumor Cell VEGF Expression on the In Vivo Efficacy of Vandetanib (ZACTIMATM; ZD6474) Anticancer Res, June 1, 2009; 29(6): 1987 - 1992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bhattacharya, J. Kwon, X. Li, E. Wang, S. Patra, J. P. Bida, Z. Bajzer, L. Claesson-Welsh, and D. Mukhopadhyay Distinct role of PLC{beta}3 in VEGF-mediated directional migration and vascular sprouting J. Cell Sci., April 1, 2009; 122(7): 1025 - 1034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Anderson, N. E. Hastings, B. R. Blackman, and R. J. Price Capillary Sprout Endothelial Cells Exhibit a CD36low Phenotype: Regulation by Shear Stress and Vascular Endothelial Growth Factor-Induced Mechanism for Attenuating Anti-Proliferative Thrombospondin-1 Signaling Am. J. Pathol., October 1, 2008; 173(4): 1220 - 1228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Halin, H. Fahrngruber, J. G. Meingassner, G. Bold, A. Littlewood-Evans, A. Stuetz, and M. Detmar Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Am. J. Pathol., July 1, 2008; 173(1): 265 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shahrara, A. E. I. Proudfoot, C. C. Park, M. V. Volin, G. K. Haines, J. M. Woods, C. H. Aikens, T. M. Handel, and R. M. Pope Inhibition of Monocyte Chemoattractant Protein-1 Ameliorates Rat Adjuvant-Induced Arthritis J. Immunol., March 1, 2008; 180(5): 3447 - 3456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Halin, N. E. Tobler, B. Vigl, L. F. Brown, and M. Detmar VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes Blood, November 1, 2007; 110(9): 3158 - 3167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Murakami, S. Iwai, S. Hiratsuka, M. Yamauchi, K. Nakamura, Y. Iwakura, and M. Shibuya Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages Blood, September 15, 2006; 108(6): 1849 - 1856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Larrivee, I. Pollet, and A. Karsan Activation of Vascular Endothelial Growth Factor Receptor-2 in Bone Marrow Leads to Accumulation of Myeloid Cells: Role of Granulocyte-Macrophage Colony-Stimulating Factor J. Immunol., September 1, 2005; 175(5): 3015 - 3024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Taylor Serum vascular markers and vascular imaging in assessment of rheumatoid arthritis disease activity and response to therapy Rheumatology, June 1, 2005; 44(6): 721 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Grisar, D. Aletaha, C. W. Steiner, T. Kapral, S. Steiner, D. Seidinger, G. Weigel, I. Schwarzinger, W. Wolozcszuk, G. Steiner, et al. Depletion of Endothelial Progenitor Cells in the Peripheral Blood of Patients With Rheumatoid Arthritis Circulation, January 18, 2005; 111(2): 204 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Bonnet and D. A. Walsh Osteoarthritis, angiogenesis and inflammation Rheumatology, January 1, 2005; 44(1): 7 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. W. Park, Y. M. Kang, J. Butterfield, M. Detmar, J. J. Goronzy, and C. M. Weyand Thrombospondin 2 Functions as an Endogenous Regulator of Angiogenesis and Inflammation in Rheumatoid Arthritis Am. J. Pathol., December 1, 2004; 165(6): 2087 - 2098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Han, G. W. Kim, J. S. Seo, S. J. Kim, K. H. Sa, J. Y. Park, J. Lee, S. Y. Kim, J. J. Goronzy, C. M. Weyand, et al. VEGF gene polymorphisms and susceptibility to rheumatoid arthritis Rheumatology, September 1, 2004; 43(9): 1173 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ferrara Vascular Endothelial Growth Factor: Basic Science and Clinical Progress Endocr. Rev., August 1, 2004; 25(4): 581 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Brown, J. Gaspar, A. Pettit, R. Lee, X. Gu, H. Wang, C. Manning, C. Voland, S. R. Goldring, M. B. Goldring, et al. ESE-1 Is a Novel Transcriptional Mediator of Angiopoietin-1 Expression in the Setting of Inflammation J. Biol. Chem., March 26, 2004; 279(13): 12794 - 12803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bussolati, A. Ahmed, H. Pemberton, R. C. Landis, F. Di Carlo, D. O. Haskard, and J. C. Mason Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration Blood, February 1, 2004; 103(3): 761 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. De Bandt, M. H. Ben Mahdi, V. Ollivier, M. Grossin, M. Dupuis, M. Gaudry, P. Bohlen, K. E. Lipson, A. Rice, Y. Wu, et al. Blockade of Vascular Endothelial Growth Factor Receptor I (VEGF-RI), but not VEGF-RII, Suppresses Joint Destruction in the K/BxN Model of Rheumatoid Arthritis J. Immunol., November 1, 2003; 171(9): 4853 - 4859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A E Koch Angiogenesis as a target in rheumatoid arthritis Ann Rheum Dis, November 1, 2003; 62(90002): ii60 - 67. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sakao, K. Tatsumi, T. Hashimoto, H. Igari, Y. Shino, H. Shirasawa, and T. Kuriyama Vascular Endothelial Growth Factor and the Risk of Smoking-Related COPD Chest, July 1, 2003; 124(1): 323 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Stevens, J. Soden, P. E. Brenchley, S. Ralph, and D. W. Ray Haplotype Analysis of the Polymorphic Human Vascular Endothelial Growth Factor Gene Promoter Cancer Res., February 15, 2003; 63(4): 812 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Maeda, T. Kawane, and N. Horiuchi Statins Augment Vascular Endothelial Growth Factor Expression in Osteoblastic Cells via Inhibition of Protein Prenylation Endocrinology, February 1, 2003; 144(2): 681 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Koyama, E. Sato, A. Tsukadaira, M. Haniuda, H. Numanami, M. Kurai, S. Nagai, and T. Izumi Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro Eur. Respir. J., December 1, 2002; 20(6): 1449 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hashimoto, I. Inoki, Y. Fujii, T. Aoki, E. Ikeda, and Y. Okada Matrix Metalloproteinases Cleave Connective Tissue Growth Factor and Reactivate Angiogenic Activity of Vascular Endothelial Growth Factor 165 J. Biol. Chem., September 20, 2002; 277(39): 36288 - 36295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dabrosin, S. Gyorffy, P. Margetts, C. Ross, and J. Gauldie Therapeutic Effect of Angiostatin Gene Transfer in a Murine Model of Endometriosis Am. J. Pathol., September 1, 2002; 161(3): 909 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Koyama, E. Sato, M. Haniuda, H. Numanami, S. Nagai, and T. Izumi Decreased Level of Vascular Endothelial Growth Factor in Bronchoalveolar Lavage Fluid of Normal Smokers and Patients with Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 382 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Matsumoto, K. Tanaka, G. Hirata, M. Hanada, S. Matsuda, T. Shuto, and Y. Iwamoto Possible Involvement of the Vascular Endothelial Growth Factor-Flt-1-Focal Adhesion Kinase Pathway in Chemotaxis and the Cell Proliferation of Osteoclast Precursor Cells in Arthritic Joints J. Immunol., June 1, 2002; 168(11): 5824 - 5831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yasuda, S. Shimizu, K. Ohhinata, S. Naito, S. Tokuyama, Y. Mori, Y. Kiuchi, and T. Yamamoto Differential roles of ICAM-1 and E-selectin in polymorphonuclear leukocyte-induced angiogenesis Am J Physiol Cell Physiol, April 1, 2002; 282(4): C917 - C925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yamashita, Y. Yonemitsu, S. Okano, K. Nakagawa, Y. Nakashima, T. Irisa, Y. Iwamoto, Y. Nagai, M. Hasegawa, and K. Sueishi Fibroblast Growth Factor-2 Determines Severity of Joint Disease in Adjuvant-Induced Arthritis in Rats J. Immunol., January 1, 2002; 168(1): 450 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. White, D. L. Livant, S. Markwart, and D. A. Arenberg Monocyte-Fibronectin Interactions, Via {alpha}5{beta}1 Integrin, Induce Expression of CXC Chemokine-Dependent Angiogenic Activity J. Immunol., November 1, 2001; 167(9): 5362 - 5366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P E C Brenchley Antagonising angiogenesis in rheumatoid arthritis Ann Rheum Dis, November 1, 2001; 60(90003): iii71 - 74. [Full Text] [PDF]
|
|
|
|
|
|
K.-Y. Kim, S.-Y. Jeong, J. Won, P.-D. Ryu, and M.-J. Nam Induction of Angiogenesis by Expression of Soluble Type II Transforming Growth Factor-beta Receptor in Mouse Hepatoma J. Biol. Chem., October 12, 2001; 276(42): 38781 - 38786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Volin, J. M. Woods, M. A. Amin, M. A. Connors, L. A. Harlow, and A. E. Koch Fractalkine: A Novel Angiogenic Chemokine in Rheumatoid Arthritis Am. J. Pathol., October 1, 2001; 159(4): 1521 - 1530. [Abstract] [Full Text]
|
|
|
|
 |
|
 M.-H. Liu, H.-K. Jin, H. S. Floten, Q. Yang, A. P. C. Yim, A. Furnary, T. F. Zioncheck, S. Bunting, and G.-W. He Vascular Endothelial Growth Factor-Mediated Endothelium-Dependent Relaxation Is Blunted in Spontaneously Hypertensive Rats J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 473 - 477. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Yang, P. Degranpré, A. Kharfi, and A. Akoum Identification of Macrophage Migration Inhibitory Factor as a Potent Endothelial Cell Growth-Promoting Agent Released by Ectopic Human Endometrial Cells J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4721 - 4727. [Abstract] [Full Text]
|
|
|
|
|
|
A. E. Koch The role of angiogenesis in rheumatoid arthritis: recent developments Ann Rheum Dis, November 1, 2000; 59(90001): i65 - 71. [Full Text] [PDF]
|
|
|
|
|
|
M. Feldmann, J. Miotla, E. Paleolog, R. Williams, A.-M. Malfait, P. Taylor, F. M Brennan, and R. N Maini Future prospects for anti-cytokine treatment Ann Rheum Dis, November 1, 2000; 59(90001): i119 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lu, T. Kasama, K. Kobayashi, Y. Yoda, F. Shiozawa, M. Hanyuda, M. Negishi, H. Ide, and M. Adachi Vascular Endothelial Growth Factor Expression and Regulation of Murine Collagen-Induced Arthritis J. Immunol., June 1, 2000; 164(11): 5922 - 5927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-S. Cho, M.-L. Cho, S.-Y. Min, W.-U. Kim, D.-J. Min, S.-S. Lee, S.-H. Park, J. Choe, and H.-Y. Kim CD40 Engagement on Synovial Fibroblast Up-Regulates Production of Vascular Endothelial Growth Factor J. Immunol., May 15, 2000; 164(10): 5055 - 5061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lu, P. Kussie, B. Pytowski, K. Persaud, P. Bohlen, L. Witte, and Z. Zhu Identification of the Residues in the Extracellular Region of KDR Important for Interaction with Vascular Endothelial Growth Factor and Neutralizing Anti-KDR Antibodies J. Biol. Chem., May 5, 2000; 275(19): 14321 - 14330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Feng, J. A. Nagy, R. A. Brekken, A. Pettersson, E. J. Manseau, K. Pyne, R. Mulligan, P. E. Thorpe, H. F. Dvorak, and A. M. Dvorak Ultrastructural Localization of the Vascular Permeability Factor/Vascular Endothelial Growth Factor (VPF/VEGF) Receptor-2 (FLK-1, KDR) in Normal Mouse Kidney and in the Hyperpermeable Vessels Induced by VPF/VEGF-expressing Tumors and Adenoviral Vectors J. Histochem. Cytochem., April 1, 2000; 48(4): 545 - 556. [Abstract] [Full Text]
|
|
|
|
|
|
M. Carlevaro, S Cermelli, R Cancedda, and F Descalzi Cancedda Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation J. Cell Sci., January 1, 2000; 113(1): 59 - 69. [Abstract] [PDF]
|
|
|
|
|
|
S. Saito, N. Yamaji, K. Yasunaga, T. Saito, S.-i. Matsumoto, M. Katoh, S. Kobayashi, and Y. Masuho The Fibronectin Extra Domain A Activates Matrix Metalloproteinase Gene Expression by an Interleukin-1-dependent Mechanism J. Biol. Chem., October 22, 1999; 274(43): 30756 - 30763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Dentelli, L. D. Sorbo, A. Rosso, A. Molinar, G. Garbarino, G. Camussi, L. Pegoraro, and M. F. Brizzi Human IL-3 Stimulates Endothelial Cell Motility and Promotes In Vivo New Vessel Formation J. Immunol., August 15, 1999; 163(4): 2151 - 2159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Brizzi, E. Battaglia, G. Montrucchio, P. Dentelli, L. Del Sorbo, G. Garbarino, L. Pegoraro, and G. Camussi Thrombopoietin Stimulates Endothelial Cell Motility and Neoangiogenesis by a Platelet-Activating Factor–Dependent Mechanism Circ. Res., April 16, 1999; 84(7): 785 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rivard, M. Silver, D. Chen, M. Kearney, M. Magner, B. Annex, K. Peters, and J. M. Isner Rescue of Diabetes-Related Impairment of Angiogenesis by Intramuscular Gene Therapy with Adeno-VEGF Am. J. Pathol., February 1, 1999; 154(2): 355 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rivard, J.-E. Fabre, M. Silver, D. Chen, T. Murohara, M. Kearney, M. Magner, T. Asahara, and J. M. Isner Age-Dependent Impairment of Angiogenesis Circulation, January 12, 1999; 99(1): 111 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Ryan, D. B. Eppler, K. E. Hagler, R. H. Bruner, P. J. Thomford, R. L. Hall, G. M. Shopp, and C. A. O'Neill Preclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal Antibody Toxicol Pathol, January 1, 1999; 27(1): 78 - 86. [Abstract] [PDF]
|
|
|
|
|
|
N. Ito, C. Wernstedt, U. Engstrom, and L. Claesson-Welsh Identification of Vascular Endothelial Growth Factor Receptor-1 Tyrosine Phosphorylation Sites and Binding of SH2 Domain-containing Molecules J. Biol. Chem., September 4, 1998; 273(36): 23410 - 23418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Giraudo, L. Primo, E. Audero, H.-P. Gerber, P. Koolwijk, S. Soker, M. Klagsbrun, N. Ferrara, and F. Bussolino Tumor Necrosis Factor-alpha Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial Cells J. Biol. Chem., August 21, 1998; 273(34): 22128 - 22135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ruckman, L. S. Green, J. Beeson, S. Waugh, W. L. Gillette, D. D. Henninger, L. Claesson-Welsh, and N. Janjic 2'-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165). INHIBITION OF RECEPTOR BINDING AND VEGF-INDUCED VASCULAR PERMEABILITY THROUGH INTERACTIONS REQUIRING THE EXON 7-ENCODED DOMAIN J. Biol. Chem., August 7, 1998; 273(32): 20556 - 20567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Ramos, M. Kuzuya, T. Esaki, S. Miura, S. Satake, T. Asai, S. Kanda, T. Hayashi, and A. Iguchi Induction of Macrophage VEGF in Response to Oxidized LDL and VEGF Accumulation in Human Atherosclerotic Lesions Arterioscler Thromb Vasc Biol, July 1, 1998; 18(7): 1188 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Kevil, D. K. Payne, E. Mire, and J. S. Alexander Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins J. Biol. Chem., June 12, 1998; 273(24): 15099 - 15103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Murohara, J. R. Horowitz, M. Silver, Y. Tsurumi, D. Chen, A. Sullivan, and J. M. Isner Vascular Endothelial Growth Factor/Vascular Permeability Factor Enhances Vascular Permeability Via Nitric Oxide and Prostacyclin Circulation, January 13, 1998; 97(1): 99 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Couper, S. R. Bryant, J. Eldrup-Jorgensen, C. E. Bredenberg, and V. Lindner Vascular Endothelial Growth Factor Increases the Mitogenic Response to Fibroblast Growth Factor-2 in Vascular Smooth Muscle Cells In Vivo via Expression of fms-Like Tyrosine Kinase-1 Circ. Res., December 19, 1997; 81(6): 932 - 939. [Abstract] [Full Text]
|
|
|
|
|
|
M. Gaudry, O. Bregerie, V. Andrieu, J. El Benna, M.-A. Pocidalo, and J. Hakim Intracellular Pool of Vascular Endothelial Growth Factor in Human Neutrophils Blood, November 15, 1997; 90(10): 4153 - 4161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Dawson, S. F. A. Pearce, R. Zhong, R. L. Silverstein, W. A. Frazier, and N. P. Bouck CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells J. Cell Biol., August 11, 1997; 138(3): 707 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Fiedler, U. Graeven, S. Ergun, S. Verago, N. Kilic, M. Stockschlader, and D. K. Hossfeld Vascular Endothelial Growth Factor, a Possible Paracrine Growth Factor in Human Acute Myeloid Leukemia Blood, March 15, 1997; 89(6): 1870 - 1875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ferrara and T. Davis-Smyth The Biology of Vascular Endothelial Growth Factor Endocr. Rev., February 1, 1997; 18(1): 4 - 25. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. A. Lutty, D. S. McLeod, C. Merges, A. Diggs, and J. Plouet Localization of Vascular Endothelial Growth Factor in Human Retina and Choroid Arch Ophthalmol, August 1, 1996; 114(8): 971 - 977. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Doi, H. Itoh, Y. Komatsu, T. Igaki, T.-H. Chun, K. Takaya, J. Yamashita, M. Inoue, T. Yoshimasa, and K. Nakao Vascular Endothelial Growth Factor Suppresses C-Type Natriuretic Peptide Secretion Hypertension, March 1, 1996; 27(3): 811 - 815. [Abstract] [Full Text]
|
|
|
|
 |
|
 S Grimmond, J Lagercrantz, C Drinkwater, G Silins, S Townson, P Pollock, D Gotley, E Carson, S Rakar, M Nordenskjold, et al. Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res., February 1, 1996; 6(2): 124 - 131. [Abstract] [PDF]
|
|
|
|
|
|
K. A. Thomas and K. A. Thomas Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent J. Biol. Chem., January 12, 1996; 271(2): 603 - 606. [Full Text] [PDF]
|
|
|
|
|
|
W. Roberts and G. Palade Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor J. Cell Sci., January 6, 1995; 108(6): 2369 - 2379. [Abstract] [PDF]
|
|
|
|
|
|
G. Bhattacharjee, I. R. Asplin, S. M. Wu, G. Gawdi, and S. V. Pizzo The Conformation-dependent Interaction of alpha 2-Macroglobulin with Vascular Endothelial Growth Factor. A NOVEL MECHANISM OF alpha 2-MACROGLOBULIN/GROWTH FACTOR BINDING J. Biol. Chem., August 25, 2000; 275(35): 26806 - 26811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Wang, D. B. Donner, and R. S. Warren Homeostatic Modulation of Cell Surface KDR and Flt1 Expression and Expression of the Vascular Endothelial Cell Growth Factor (VEGF) Receptor mRNAs by VEGF J. Biol. Chem., May 19, 2000; 275(21): 15905 - 15911. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
